Keefe, Bruyette & Woods Maintains Outperform on MetLife, Raises Price Target to $87
Portfolio Pulse from Benzinga Newsdesk
Keefe, Bruyette & Woods analyst Ryan Krueger maintains an Outperform rating on MetLife (NYSE:MET) and raises the price target from $82 to $87.
April 10, 2024 | 3:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MetLife's Outperform rating is maintained by Keefe, Bruyette & Woods, with the price target increased from $82 to $87.
The increase in price target by a reputable analyst firm like Keefe, Bruyette & Woods typically signals a strong bullish sentiment towards the stock, suggesting a positive short-term impact on MetLife's stock price. The maintenance of an Outperform rating further reinforces the positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100